0000950170-23-070534.txt : 20231214 0000950170-23-070534.hdr.sgml : 20231214 20231214195148 ACCESSION NUMBER: 0000950170-23-070534 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230213 FILED AS OF DATE: 20231214 DATE AS OF CHANGE: 20231214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cunningham Steven E CENTRAL INDEX KEY: 0001575452 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35503 FILM NUMBER: 231488547 MAIL ADDRESS: STREET 1: 2500 LAKE COOK ROAD CITY: RIVERWOODS STATE: IL ZIP: 60015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Enova International, Inc. CENTRAL INDEX KEY: 0001529864 STANDARD INDUSTRIAL CLASSIFICATION: PERSONAL CREDIT INSTITUTIONS [6141] IRS NUMBER: 453190813 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 175 WEST JACKSON BLVD. STREET 2: SUITE 1000 CITY: CHICAGO STATE: IL ZIP: 60604 BUSINESS PHONE: 312-568-4200 MAIL ADDRESS: STREET 1: 175 WEST JACKSON BLVD. STREET 2: SUITE 1000 CITY: CHICAGO STATE: IL ZIP: 60604 4/A 1 ownership.xml 4/A X0508 4/A 2023-02-13 2023-02-15 0001529864 Enova International, Inc. ENVA 0001575452 Cunningham Steven E C/O ENOVA INTERNATIONAL, INC. 175 W. JACKSON BOULEVARD, SUITE 600 CHICAGO IL 60604 false true false false Chief Financial Officer false Common Stock, par value $0.00001 2023-02-13 4 F false 3377 50.21 D 188953 D Includes timed-based restricted stock units previously granted to the Reporting Person. The original Form 4, filed February 15, 2023, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the sale of 3,577 shares for the payment of tax liability issued in accordance with Rule 16b-3, when the correct reported sale of shares should have been 3,377 shares. As a result of the administrative error, the total number of securities beneficially owned following the transaction should be reported as 188,953 instead of the previously reported 188,753. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. /s/ Sean Rahilly, as attorney in fact 2023-12-14